Lung Neoplasm Malignant clinical trials

Explore recruiting lung neoplasm malignant clinical trials.

Recruiting lung neoplasm malignant studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lung Neoplasm Malignant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Boosting osimertinib Blood Brain Barrier penetration in patients with epidermal growth factor receptor mutated non-small cell lung cancer (OSIBBBOOST)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A single arm phase II study evaluating intracranial efficacy of Sacituzumab govitecan (SG) with bevacizumab in patients with asymptomatic brain metastases from non-small cell lung cancer (NSCLC)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

KEYMAKER-U01 Substudy 01G: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents in Combination With Pembrolizumab With or Without Platinum-based Chemotherapy in Treatment-Naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)

Greece, Italy, Spain, Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Lung Neoplasm Malignant trials by city

Lung Neoplasm Malignant in Toronto Lung Neoplasm Malignant in Vancouver Lung Neoplasm Malignant in Montreal Lung Neoplasm Malignant in Calgary Lung Neoplasm Malignant in Edmonton Lung Neoplasm Malignant in Ottawa Lung Neoplasm Malignant in Winnipeg Lung Neoplasm Malignant in Quebec City Lung Neoplasm Malignant in Hamilton Lung Neoplasm Malignant in Kitchener Lung Neoplasm Malignant in London Lung Neoplasm Malignant in Halifax Lung Neoplasm Malignant in New York Lung Neoplasm Malignant in Los Angeles Lung Neoplasm Malignant in Chicago Lung Neoplasm Malignant in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease